about
The Genetics of IgA Nephropathy: An Overview from Western CountriesAnti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathwaysExploring the genetic basis of early-onset chronic kidney disease.Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney diseaseFrequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageingMultiple kidney cysts in thin basement membrane disease with proteinuria and kidney function impairment.Pathogenesis of glomerular haematuria.Podocyte Depletion in Thin GBM and Alport Syndrome.A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population.A Novel COL4A4 Mutation Identified in a Chinese Family with Thin Basement Membrane Nephropathy.Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous NephropathyFamilial haematuria: when to consider genetic testing.Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review.Advances in renal genetic diagnosis.Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease.Genetic background influences cardiac phenotype in murine chronic kidney disease.Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS.Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation
P2860
Q28085181-C670FFFB-A9A1-450E-BE1B-AADC830BD339Q30405346-8A474788-2FE3-4DFE-9127-8BB9A59D5E70Q34508359-410D4F7C-1462-4A52-8509-6D47A7BA46F5Q34517419-47ABFF8A-4813-4863-B6AA-D674F8E4FFBEQ34712797-DE5ACA6E-C589-4283-964A-61157EED7A19Q35227568-608E853D-FFAD-4BAC-B2A2-AD84EBF5E5C7Q35567846-9DC1AB6A-B8EF-47ED-8C28-1FDA308731BEQ36021415-56F7EABD-3186-402F-A7D5-4FB7A319AEC3Q36319999-5DB98187-C6AD-4D99-A3B7-7652BC4AE582Q36528259-E9259908-576E-4505-9DD4-5054CCC496FFQ37699835-F17BBC88-D335-4E04-AFB1-AAB48C2BF7E8Q38204264-E7B41E0A-EED6-438D-AD60-511E6D099A2BQ38484336-A5D5302B-EB9A-468C-873C-35A931CC48F6Q38673027-3B7FFB50-D20E-4B26-A0EE-221CB0ECAE34Q42068957-B60838E2-549B-4245-8E71-78A610BED981Q47224780-0AEF3FDD-7CF3-4D07-BDBC-C1C92FD2F127Q47401355-6BFE865E-575B-47AF-8A7A-25C64967D4E7Q48249735-2FA001D1-D11D-46CE-A341-6DD15791F61DQ50354065-3D80BAAF-4E0F-4557-AB5F-A9C7EC01AADAQ50354066-CEB1D5E8-34BF-4FE9-A7D6-05818F4FACF5Q55346878-B80CC543-B323-4D4C-85E8-16587B0DF3F6Q58555894-4F89DA53-6553-4FAF-8A74-B781CF0A175D
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Molecular genetics of familial hematuric diseases.
@en
type
label
Molecular genetics of familial hematuric diseases.
@en
prefLabel
Molecular genetics of familial hematuric diseases.
@en
P2860
P356
P1476
Molecular genetics of familial hematuric diseases.
@en
P2093
Alkis Pierides
P2860
P304
P356
10.1093/NDT/GFT253
P407
P577
2013-09-17T00:00:00Z